Page last updated: 2024-12-08

cortol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID246873
CHEMBL ID1908046
CHEBI ID3898
SCHEMBL ID607309
MeSH IDM0044580

Synonyms (29)

Synonym
a-cortol
nsc 60459
3alpha,11beta,17,20alpha,21-pentahydroxypregnane
20alpha-cortol
5ihl40ehnb ,
5beta-pregnane-3alpha,11beta,17,20,21-pentol
pregnane-3,11,17,20,21-pentol, (3alpha,5beta,11beta,20s)-
unii-5ihl40ehnb
3.alpha.,17,20.alpha.,21-pentahydroxypregnane
pregnane-3,17,20,21-pentol, (3.alpha.,5.beta.,11.beta.,20s)-
nsc-60459
.alpha.-cortol
20.alpha.-cortol
nsc60459
5.beta.-pregnane-3.alpha.,17,20.alpha.,21-pentol
C05482
516-38-1
cortol ,
(3r,5r,8s,9s,10s,11s,13s,14s,17r)-17-[(1s)-1,2-dihydroxyethyl]-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,11,17-triol
chebi:3898 ,
CHEMBL1908046
.alpha.-cortol [mi]
pregnane-3,11,17,20,21-pentol, (3.alpha.,5.beta.,11.beta.,20s)-
3.alpha.,11.beta.,17,20.alpha.,21-pentahydroxypregnane
SCHEMBL607309
alpha-cortol
5beta-pregnane-3alpha, 11beta ,17, 20s, 21-pentol
Q27106232
DTXSID90862093
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
21-hydroxy steroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Biochemical pathways: part I0466

Bioassays (2)

Assay IDTitleYearJournalArticle
AID624618Specific activity of expressed human recombinant UGT2B42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.94 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index47.05 (26.88)
Search Engine Supply Index2.70 (0.95)

This Compound (33.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (77.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]